There's also no account required, and you still get free updates. On the other hand, you don't get access to AI features, ...
Anthropic is launching a new feature for its Claude AI that offers many of the same benefits of projects such as OpenClaw.
A subset of patients with oesophageal cancer shows a marked response to neoadjuvant chemoradiotherapy, yet post-treatment assessment by endoscopy or imaging remains unreliable. We report a 65-year-old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results